A study to compare point based and volumetric brachytherapy in carcinoma cervix
Not Applicable
Completed
- Conditions
- Health Condition 1: C53- Malignant neoplasm of cervix uteri
- Registration Number
- CTRI/2020/10/028227
- Lead Sponsor
- Sri Venkateswara Institute Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Histo-pathologically confirmed carcinoma of uterine cervix cases.
2.Patients with stage IB2 to IVA according to International Federation of Gynecology and Obstetrics(FIGO).
3. Eastern Cooperative Oncology Group (ECOG) performance score of 0-2.
4. Patients who have signed approved informed consent.
Exclusion Criteria
1. Patients previously treated with surgery or chemotherapy or radiotherapy.
2. FIGO stage IA, IB1, IIIC2, IVA with VVF and IVB cervical cancer.
3. Patient of age > 65 years.
4. ECOG performance score 3-4.
5. Patients who are not willing to sign approved informed consent.
5. Pregnant women and lactating mothers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor response rateTimepoint: 1 month after treatment completion
- Secondary Outcome Measures
Name Time Method ate toxicitiesTimepoint: 6 months after treatment completion